Matthew Duchars

Matthew Duchars is a highly experienced biotechnology executive with a strong background in vaccine development and strategic leadership. Currently serving as Chief Executive Officer for CHAIN Biotechnology Ltd and Genie BioLogic Ltd, Matthew Duchars focuses on advancing genetically enhanced probiotic applications and providing essential guidance for early-stage biopharmaceutical development. Previously, Matthew Duchars held the position of Chief Executive Officer at VMIC UK, leading the UK's first dedicated Vaccines Manufacturing Innovation Centre. Other notable roles include Vice President of Product Development at Emergent BioSolutions and Senior Director Global Science at United Therapeutics, among various leadership positions in prominent biotech firms. Matthew Duchars earned a PhD in Microbial Physiology and a BSc in Microbiology from The University of Sheffield.